Informações:
Falhas:
ID
39594
Descrição
The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01795248
Link
https://clinicaltrials.gov/show/NCT01795248
Palavras-chave
Versões (1)
- 01/02/2020 01/02/2020 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
1 de fevereiro de 2020
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Gestational Diabetes Mellitus NCT01795248
Eligibility Gestational Diabetes Mellitus NCT01795248
- StudyEvent: Eligibility
Similar models
Eligibility Gestational Diabetes Mellitus NCT01795248
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Informed Consent
Item
informed oral and written consent
boolean
C0021430 (UMLS CUI [1])
Gestational Diabetes | Plasma Glucose Measurement | Oral Glucose Tolerance Test
Item
previous diagnosis of gdm according to current danish guidelines (mainly pg concentrationa t 120 min after 75 g ogtt ≥ 9.0 mm) during pregnancy within the last 5 years
boolean
C0085207 (UMLS CUI [1])
C0202042 (UMLS CUI [2])
C0029161 (UMLS CUI [3])
C0202042 (UMLS CUI [2])
C0029161 (UMLS CUI [3])
Age
Item
age >18 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
25 kg/m2 < bmi < 45 kg/m2
boolean
C1305855 (UMLS CUI [1])
Glucose tolerance test normal | Impaired fasting glucose | Impaired glucose tolerance
Item
ngt, ifg and or igt
boolean
C0438251 (UMLS CUI [1])
C1272092 (UMLS CUI [2])
C0151671 (UMLS CUI [3])
C1272092 (UMLS CUI [2])
C0151671 (UMLS CUI [3])
Contraceptive methods | Pregnancy test negative
Item
safe contraception and negative pregnancy test
boolean
C0700589 (UMLS CUI [1])
C0427780 (UMLS CUI [2])
C0427780 (UMLS CUI [2])
Diabetes Mellitus
Item
patients with diabetes
boolean
C0011849 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hba1c ≥6.5%
boolean
C0474680 (UMLS CUI [1])
Pancreatitis Previous | Neoplastic disease Previous
Item
patients with previous pancreatitis or previous neoplasia
boolean
C0030305 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C1882062 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
C0205156 (UMLS CUI [1,2])
C1882062 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
pregnant or breast feeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Anemia | Hemoglobin measurement
Item
anaemia (haemoglobin <7 mm)
boolean
C0002871 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0518015 (UMLS CUI [2])
Pregnancy, Planned
Item
women planning to become pregnant within the next 5 years
boolean
C0032992 (UMLS CUI [1])
Gender | Contraceptive methods Except Intrauterine Devices | Contraceptive methods Except Oral Contraceptives
Item
women using other contraception than intrauterine device (iud) or oral contraceptives. women who do not use safe contraception will be offered application of an iud.
boolean
C0079399 (UMLS CUI [1])
C0700589 (UMLS CUI [2,1])
C0332300 (UMLS CUI [2,2])
C0021900 (UMLS CUI [2,3])
C0700589 (UMLS CUI [3,1])
C0332300 (UMLS CUI [3,2])
C0009905 (UMLS CUI [3,3])
C0700589 (UMLS CUI [2,1])
C0332300 (UMLS CUI [2,2])
C0021900 (UMLS CUI [2,3])
C0700589 (UMLS CUI [3,1])
C0332300 (UMLS CUI [3,2])
C0009905 (UMLS CUI [3,3])
Statins | Adrenal Cortex Hormones | Hormone Therapy | Exception Estrogens | Exception Progestins
Item
women treated with statins, corticosteroids or other hormone therapy (except estrogens and gestagens)
boolean
C0360714 (UMLS CUI [1])
C0001617 (UMLS CUI [2])
C0279025 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C0014939 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0033306 (UMLS CUI [5,2])
C0001617 (UMLS CUI [2])
C0279025 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C0014939 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0033306 (UMLS CUI [5,2])
Alcohol abuse | Narcotic Abuse
Item
ongoing abuse of alcohol or narcotics
boolean
C0085762 (UMLS CUI [1])
C0524661 (UMLS CUI [2])
C0524661 (UMLS CUI [2])
Liver Dysfunction | Increased liver transaminases
Item
impaired hepatic function (liver transaminases >3 times upper normal limit)
boolean
C0086565 (UMLS CUI [1])
C4478596 (UMLS CUI [2])
C4478596 (UMLS CUI [2])
Renal Insufficiency | Creatinine measurement, serum | Albuminuria
Item
impaired renal function (se-creatinine >120 μm and/or albuminuria)
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0001925 (UMLS CUI [3])
C0201976 (UMLS CUI [2])
C0001925 (UMLS CUI [3])
Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure
Item
uncontrolled hypertension (systolic blood pressure >180 mmhg, diastolic blood pressure >100 mmhg)
boolean
C1868885 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
Condition Interferes with Study Subject Participation Status
Item
any condition that the investigator feels would interfere with trial participation
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
Investigational New Drugs
Item
receiving any investigational drug within the last 3 months
boolean
C0013230 (UMLS CUI [1])